Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.67
Delayed Data
As of Jul 31
 +0.02 / +3.08%
Today’s Change
0.51
Today|||52-Week Range
3.72
-4.27%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close0.65
Today’s open0.64
Day’s range-- - --
Volume74,370
Average volume (3 months)220,658
Market cap$23.3M
Dividend yield--
Data as of 07/31/2015

Growth & Valuation

Earnings growth (last year)+30.47%
Earnings growth (this year)-7.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+59.96%
P/E ratioNM
Price/Sales8.86
Price/Book0.72

Competitors

 Today’s
change
Today’s
% change
NVGNNovogen Ltd+0.01+0.29%
CLRBCellectar Bioscience...-0.19-5.78%
PRPHProPhase Labs Inc0.000.00%
ABIOARCA Biopharma Inc-0.12-9.70%
Data as of 07/31/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$1.7M
Annual profit (last year)-$19.4M
Net profit margin-1,119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts